These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25166445)

  • 1. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
    Barbosa M; Bennett MI; Verissimo R; Carvalho D
    Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
    Garoushi S; Johnson MI; Tashani OA
    Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.
    Alkan H; Ardic F; Erdogan C; Sahin F; Sarsan A; Findikoglu G
    Pain Med; 2013 Dec; 14(12):1933-43. PubMed ID: 23924395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires.
    Li J; Feng Y; Han J; Fan B; Wu D; Zhang D; Du D; Li H; Lim J; Wang J; Jin Y; Fu Z
    Pain Physician; 2012; 15(2):179-86. PubMed ID: 22430656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
    Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
    Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study.
    Yucel A; Senocak M; Kocasoy Orhan E; Cimen A; Ertas M
    J Pain; 2004 Oct; 5(8):427-32. PubMed ID: 15501424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.
    Yurdakul OV; Rezvani A; Kucukakkas O; Tolu S; Kilicoglu MS; Aydin T
    Turk Neurosurg; 2019; 29(5):683-688. PubMed ID: 31192441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
    Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
    Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
    Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
    J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the S-LANSS in the community setting.
    Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
    Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.